The pharmaceutical patent landscape is undergoing changes as the Supreme Court of the United States and the Federal Circuit review an increasing number of Patent Trial and Appeal Board inter partes review proceeding decisions. While the appellate courts give some deference to the PTAB’s implementation of the America Invents Act, we are seeing more dissenting opinions and some panels are striking down the PTAB’s interpretation of the AIA. During this webinar, Janelle Waack and Greg Parker will highlight relevant trends, address issues and offer insights pertinent to the pharmaceutical industry.
Topics will include:
- Addressing Supreme Court and Federal Circuit decisions impacting IPR claim interpretation, expert testimony, amendment of claims, estoppel, burden shifting and raising new arguments in reply briefs
- An overview of how to preserve issues in the IPR record for appeal
- The impact of recent Supreme Court and Federal Circuit decisions on strategies for pharmaceutical patents undergoing review at the PTAB
For more information and registration, visit the IP Counsel Exchange website.